(Q46227382)

20 December 2017

meta-analysis

0 references

title

Retinal layer segmentation in multiple sclerosis: a systematic review and meta-analysis (English)

1 reference

20 December 2017

0 references

1 reference

2

Laura J Balcer

1 reference

20 December 2017

3

Peter A Calabresi

1 reference

20 December 2017

11

Friedemann Paul

1 reference

20 December 2017

Axel Petzold

1

object named as

Axel Petzold

1 reference

20 December 2017

Olivier Outteryck

10

object named as

Olivier Outteryck

1 reference

20 December 2017

Teresa C Frohman

5

object named as

Teresa C Frohman

1 reference

20 December 2017

author name string

Fiona Costello

4

1 reference

20 December 2017

Elliot M Frohman

6

1 reference

20 December 2017

Elena H Martinez-Lapiscina

7

1 reference

20 December 2017

Ari J Green

8

1 reference

20 December 2017

Randy Kardon

9

1 reference

20 December 2017

Sven Schippling

12

1 reference

20 December 2017

Patrik Vermersch

13

1 reference

20 December 2017

Pablo Villoslada

14

1 reference

20 December 2017

Lisanne J Balk

15

1 reference

20 December 2017

ERN-EYE IMSVISUAL

16

1 reference

20 December 2017

publication date

12 September 2017

1 reference

20 December 2017

published in

Lancet Neurology

1 reference

20 December 2017

volume

16

1 reference

20 December 2017

issue

10

1 reference

20 December 2017

page(s)

797-812

1 reference

20 December 2017

Optical coherence tomography

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Computational optical coherence tomography [Invited]

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Vision and vision-related outcome measures in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Trans-synaptic axonal degeneration in the visual pathway in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal ganglion cell and inner plexiform layer thinning in clinically isolated syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The afferent visual pathway: designing a structural-functional paradigm of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Afferent visual pathways in multiple sclerosis: a review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The APOSTEL recommendations for reporting quantitative optical coherence tomography studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The investigation of acute optic neuritis: a review and proposed protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Clinical approach to optic neuritis: pitfalls, red flags and differential diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The clinical profile of optic neuritis. Experience of the Optic Neuritis Treatment Trial. Optic Neuritis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The temporal evolution of structural and functional measures after acute optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Defining the clinical course of multiple sclerosis: the 2013 revisions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The OSCAR-IB consensus criteria for retinal OCT quality assessment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Spectral-domain optical coherence tomography: a comparison of modern high-resolution retinal imaging systems

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Outer retinal changes following acute optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

A dam for retrograde axonal degeneration in multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal nerve fiber layer thickness and neurologic disability in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Ganglion cell analysis in acute optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Analysis of retinal nerve fibre layer, visual evoked potentials and relative afferent pupillary defect in multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Evaluation of the Innermost Retinal Layers and Visual Evoked Potentials in Patients with Multiple Sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The evaluation of the retinal nerve fiber layer in multiple sclerosis with special-domain optical coherence tomography.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Evaluation of inner retinal layers in patients with multiple sclerosis or neuromyelitis optica using optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Reduced retinal nerve fiber layer and macular thickness in patients with multiple sclerosis with no history of optic neuritis identified by the use of spectral domain high-definition optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Neural networks to identify multiple sclerosis with optical coherence tomography

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal axonal loss begins early in the course of multiple sclerosis and is similar between progressive phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Comparative diagnostic accuracy of ganglion cell-inner plexiform and retinal nerve fiber layer thickness measures by Cirrus and Spectralis optical coherence tomography in relapsing-remitting multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Pattern electroretinogram in neuromyelitis optica and multiple sclerosis with or without optic neuritis and its correlation with FD-OCT and perimetry

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Benign Multiple Sclerosis is Associated with Reduced Thinning of the Retinal Nerve Fiber and Ganglion Cell Layers in Non-Optic-Neuritis Eyes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Inner nuclear layer thickening is inversley proportional to retinal ganglion cell loss in optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

OCT and Visual Field Changes as Useful Markers for Follow-up of Axonal Loss in Multiple Sclerosis in Egyptian Patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical coherence tomography indicates disease activity prior to clinical onset of central nervous system demyelination.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal nerve fiber layer thickness in benign multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Cerebrospinal fluid neurofilament light chain levels predict visual outcome after optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Tracking changes over time in retinal nerve fiber layer and ganglion cell-inner plexiform layer thickness in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Analysis of spectral domain optical coherence tomography measurements in optic neuritis: differences in neuromyelitis optica, multiple sclerosis, isolated optic neuritis and normal healthy controls.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal degeneration in primary-progressive multiple sclerosis: A role for cortical lesions?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Comparison of retinal nerve fiber layer measured by time domain and spectral domain optical coherence tomography in optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical coherence tomography reflects brain atrophy in multiple sclerosis: A four-year study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical Coherence Tomography Reveals Distinct Patterns of Retinal Damage in Neuromyelitis Optica and Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal architecture and mfERG: Optic nerve head component response characteristics in MS

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Evaluation of retinal nerve fiber layer thickness measured by optical coherence tomography in Moroccan patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Transsynaptic retinal degeneration in optic neuropathies: optical coherence tomography study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Ganglion cell loss in relation to visual disability in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical Coherence Tomography for the Detection of Remote Optic Neuritis in Multiple Sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optic neuritis interferes with optical coherence tomography and magnetic resonance imaging correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The promise and problems of meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Can meta-analysis be salvaged?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Optical coherence tomography in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The impact of utilizing different optical coherence tomography devices for clinical purposes and in multiple sclerosis trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The fundamental plan of the retina

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Autoimmunity in visual loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Trans-synaptic Retrograde Degeneration in the Human Visual System: Slow, Silent, and Real

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Timing of retinal neuronal and axonal loss in MS: a longitudinal OCT study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Progressive Loss of Retinal Ganglion Cells and Axons in Nonoptic Neuritis Eyes in Multiple Sclerosis: A Longitudinal Optical Coherence Tomography Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

High resolution spectral domain optical coherence tomography (SD-OCT) in multiple sclerosis: the first follow up study over two years.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal inner nuclear layer volume reflects response to immunotherapy in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Diagnostic accuracy of retinal abnormalities in predicting disease activity in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Visual pathway neurodegeneration winged by mitochondrial dysfunction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Mitochondrial changes within axons in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal ganglion cell layer thinning within one month of presentation for optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Dynamics of retinal injury after acute optic neuritis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal ganglion cell analysis in multiple sclerosis and optic neuritis: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

The clinical spectrum of microcystic macular edema

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Dynamic formation of macular microcysts independent of vitreous traction changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Retinal glymphatic system: an explanation for transient retinal layer volume changes?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Microcystic macular oedema in multiple sclerosis is associated with disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

RETINAL VASCULAR CYSTOID MACULAR EDEMA: Review and New Theory

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

A simple sign for recognizing off-axis OCT measurement beam placement in the context of multicentre studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Reliability of Intra-Retinal Layer Thickness Estimates

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Usefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Ocular pathology in multiple sclerosis: retinal atrophy and inflammation irrespective of disease duration

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Pattern electroretinography (PERG) and an integrated approach to visual pathway diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

Neuroprotection and visual function after optic neuritis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2817%2930278-8

7 January 2021

10.1016/S1474-4422(17)30278-8

Identifiers

DOI

1 reference

20 December 2017

1 reference

20 December 2017